Tag: regulatory standards

Batch Variability and Bioequivalence: Acceptable Limits Explained

Barbara Lalicki June 11, 2026 Pharmacy 1 Comments
Batch Variability and Bioequivalence: Acceptable Limits Explained

Explore how batch variability impacts bioequivalence standards. Learn why the 80-125% rule may be flawed and how new Between-Batch methods improve generic drug safety.

read more